Sort
48,018 grants matching “immunotherapy”
Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
$371,444Joanne B Weidhaas · University Of California Los Angeles · R01 · FY2021 · CA
Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
$371,444Joanne B Weidhaas · University Of California Los Angeles · R01 · FY2019 · CA
Germ-line miRNA binding site variants as biomarkers of toxicity and response to checkpoint inhibition
$371,444Joanne B Weidhaas · University Of California Los Angeles · R01 · FY2020 · CA
The Differentiation and Function of heterogeneous populations of Allergen-specific Lung-resident Th2 CD4+ memory cells
$371,425Marion Pepper · University Of Washington · R01 · FY2024 · AI
The Role of KV1.3 in Effector T cells
$371,384Peter A Calabresi · Johns Hopkins University · R01 · FY2008 · NS
TARGETED ONCOGENESIS AND DIABETES
$371,357University Of California San Francisco · R37 · FY2000 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$371,351Umar Mahmood · Massachusetts General Hospital · R01 · FY2019 · CA
Platelet Factor 8 As A Novel Therapy for Hemophilia A
$371,335Mortimer Poncz · Children'S Hosp Of Philadelphia · P01 · FY2011 · HL
NKG2D receptor and control adaptive immunity
$371,315Andreas Diefenbach · New York University School Of Medicine · R01 · FY2006 · AI
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$371,300Adam M Sonabend · Northwestern University At Chicago · R01 · FY2020 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$371,300Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2020 · NS
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
$371,300Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · AI
Regulation of gamma delta T cell immunoediting by novel phosphoantigens
$371,265Andrew J Wiemer · University Of Connecticut Storrs · R01 · FY2018 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$371,255David G Denardo · Washington University · P50 · FY2018 · CA
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
$371,250Guangjie Cheng · University Of Alabama At Birmingham · R01 · FY2022 · AI
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
$371,250Wendy T Watford · University Of Georgia · R01 · FY2014 · AI
Biobehavioral Role of Brain Kynurenine Metabolism in Mental Illness
$371,250Jason C O'Connor · University Of Texas Hlth Science Center · R01 · FY2010 · MH
Origin and Function of Double Negative T cells in Lupus
$371,250Andre Ballesteros-Tato · University Of Alabama At Birmingham · R56 · FY2020 · AI
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
$371,250Wendy T Watford · University Of Georgia · R01 · FY2015 · AI
MAP3K8-mediated regulation of adaptive immune responses and autoimmunity
$371,250Wendy T Watford · University Of Georgia · R01 · FY2016 · AI
Nontoxic Strategies to Establish Allochimerism in Mice
$371,250University Of Minnesota Twin Cities · R01 · FY2004 · HL
Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma
$371,250Prabodhika Mallikaratchy · Herbert H. Lehman College · SC1 · FY2019 · GM
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
$371,250Guangjie Cheng · University Of Alabama At Birmingham · R01 · FY2019 · AI
Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma
$371,250Prabodhika Mallikaratchy · Herbert H. Lehman College · SC1 · FY2020 · GM
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
$371,250Guangjie Cheng · University Of Alabama At Birmingham · R01 · FY2021 · AI